chartexchange

SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes

GlobeNewswire Inc. | Oct 13, 2026 8:30 AM EDT

Fast Track designation recognizes the potential of SAB-142 to address an unmet medical need for people with Stage 3 type 1 diabetes

Read original article